Last quarter (Q3 2022), Bellicum Pharmaceuticals's total revenue was $1.00M, a decrease of -80.00% from the same quarter last year. In Q3, Bellicum Pharmaceuticals's net income was $-7.21M. See Bellicum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 1.50M	$ 6.20M	$ 500.00K	$ 7.14M	$ 1.12M	$ 185.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 26.24M	$ 30.59M	$ 54.58M	$ 94.51M	$ 96.59M	$ 87.57M
Operating Income	$ -24.74M	$ -24.39M	$ -54.08M	$ -87.36M	$ -95.47M	$ -87.39M
Net Non Operating Interest Income Expense	$ 46.00K	$ 28.00K	$ -2.27M	$ -2.93M	$ -2.56M	$ -2.62M
Other Income Expense	$ 8.45M	$ 14.65M	$ 48.63M	$ -22.18M	$ -10.00K	$ -1.77M
Pretax Income	$ -16.25M	$ -9.71M	$ -7.72M	$ -112.48M	$ -98.04M	$ -91.78M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -16.25M	$ -9.71M	$ -7.72M	$ -112.48M	$ -98.04M	$ -91.78M
Basic EPS	$ -0.49	$ -0.84	$ -1.34	$ -24.01	$ -24.37	$ -28.90
Diluted EPS	$ -0.50	$ -0.84	$ -1.34	$ -24.01	$ -24.37	$ -28.90
Basic Average Shares	$ 108.24M	$ 11.50M	$ 5.76M	$ 4.68M	$ 4.02M	$ 3.17M
Diluted Average Shares	$ 108.24M	$ 11.50M	$ 5.76M	$ 4.68M	$ 4.02M	$ 3.17M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 26.24M	$ 30.59M	$ 54.58M	$ 94.51M	$ 96.59M	$ 87.57M
Net Income From Continuing And Discontinued Operation	$ -16.25M	$ -9.71M	$ -7.72M	$ -112.48M	$ -98.04M	$ -91.78M
Normalized Income	$ -22.63M	$ -24.35M	$ -56.35M	$ -93.28M	$ -98.04M	$ -90.00M
Interest Expense	-	$ 4.00K	$ 2.66M	$ 4.28M	$ 4.20M	$ 3.67M
EBIT	$ -16.25M	$ -9.70M	$ -5.06M	$ -108.20M	$ -93.84M	$ -88.11M
EBITDA	$ -16.22M	$ -9.56M	$ -3.19M	$ -99.69M	$ -87.14M	$ -84.54M

Currency in USD

Bellicum Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing